Glioma
- A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
- Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
- Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
- Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
- Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
- Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression
- Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
- Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells
- Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor
